TEMBEXA Trademark

Trademark Overview


On Wednesday, August 7, 2024, a trademark application was filed for TEMBEXA with the United States Patent and Trademark Office. The USPTO has given the TEMBEXA trademark a serial number of 98687461. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 18, 2025. This trademark is owned by Emergent Biodefense Operations Lansing LLC. The TEMBEXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating viral infections and diseases; antiviral drugs for medical purposes; therapeutic drugs and agents being pharmaceutical preparations for treating viral infections and diseases; therapeutic formulations being pharmaceutical preparations for treating viral infections and diseases; antivirals; pharmaceutical preparations in the nature of anti-viral therapy preparations; antiviral pills for pharmaceutical purposes; antiviral medicines for human purposes; Pharmaceutical preparations for the prevention of infections caused by DNA viruses; drugs for medical purposes, namely, anti-infectives; therapeutic formulations for treating viral infections and diseases, namely, antivirals and anti-viral therapy preparations
tembexa

General Information


Serial Number98687461
Word MarkTEMBEXA
Filing DateWednesday, August 7, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements


Description of MarkThe mark consists of the stylized working TEMBEXA in purple, with the 'X' in an exaggerated format.
Goods and ServicesPharmaceutical preparations for treating viral infections and diseases; antiviral drugs for medical purposes; therapeutic drugs and agents being pharmaceutical preparations for treating viral infections and diseases; therapeutic formulations being pharmaceutical preparations for treating viral infections and diseases; antivirals; pharmaceutical preparations in the nature of anti-viral therapy preparations; antiviral pills for pharmaceutical purposes; antiviral medicines for human purposes; Pharmaceutical preparations for the prevention of infections caused by DNA viruses; drugs for medical purposes, namely, anti-infectives; therapeutic formulations for treating viral infections and diseases, namely, antivirals and anti-viral therapy preparations
Indication of Colors claimedThe color(s) purple is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmergent Biodefense Operations Lansing LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLansing, MI 48906

Party NameEmergent Biodefense Operations Lansing LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLansing, MI 48906

Trademark Events


Event DateEvent Description
Wednesday, February 5, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Sunday, February 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 24, 2025ASSIGNED TO EXAMINER
Monday, February 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NON-FINAL ACTION WRITTEN
Monday, February 24, 2025NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 26, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 5, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 7, 2024NEW APPLICATION ENTERED